149 related articles for article (PubMed ID: 8053715)
21. Molecular basis of blistering skin diseases.
McGrath JA; Eady RA
Hosp Med; 1998 Jan; 59(1):28-32. PubMed ID: 9798561
[TBL] [Abstract][Full Text] [Related]
22. Immunoadsorption in dermatology.
Schmidt E; Zillikens D
Arch Dermatol Res; 2010 May; 302(4):241-53. PubMed ID: 20049466
[TBL] [Abstract][Full Text] [Related]
23. Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.
Hertl M; Zillikens D; Borradori L; Bruckner-Tuderman L; Burckhard H; Eming R; Engert A; Goebeler M; Hofmann S; Hunzelmann N; Karlhofer F; Kautz O; Lippert U; Niedermeier A; Nitschke M; Pfütze M; Reiser M; Rose C; Schmidt E; Shimanovich I; Sticherling M; Wolff-Franke S
J Dtsch Dermatol Ges; 2008 May; 6(5):366-73. PubMed ID: 18201220
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
[TBL] [Abstract][Full Text] [Related]
25. Blistering diseases of the skin.
Buchman JS
Clin Podiatr Med Surg; 1996 Jan; 13(1):91-108. PubMed ID: 8849935
[TBL] [Abstract][Full Text] [Related]
26. [A difficult impetigo or an autoimmune bullous dermatosis in a child?].
Majamaa H; Vaalasti A; Reunala T
Duodecim; 2000; 116(24):2777-9. PubMed ID: 12077880
[No Abstract] [Full Text] [Related]
27. [Diagnostic significance of autoantibodies in bullous dermatoses].
Messer G; Meurer M
Dtsch Med Wochenschr; 2001 Jan; 126(4):79-82. PubMed ID: 11218565
[No Abstract] [Full Text] [Related]
28. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses.
Ghohestani RF; Nicolas JF; Rousselle P; Claudy AL
Arch Dermatol; 1997 Sep; 133(9):1102-7. PubMed ID: 9301587
[TBL] [Abstract][Full Text] [Related]
29. [Immunofluorescence techniques applied to the diagnosis of autoimmune bullous skin diseases of the dermoepidermal junction].
Nicolas JF; Machado P; Cozzani E; Schmitt D
Ann Dermatol Venereol; 1993; 120(10):715-22. PubMed ID: 8161107
[No Abstract] [Full Text] [Related]
30. [An alternative to immunofluorescence on frozen tissue for the diagnosis of sub-epidermal auto-immune bullous dermatosis].
Heller M; Dachez R; Delestaing G; Prost C
Bull Assoc Anat (Nancy); 1995 Jun; 79(245):21-7. PubMed ID: 8534921
[TBL] [Abstract][Full Text] [Related]
31. Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen.
Chen KR; Shimizu S; Miyakawa S; Ishiko A; Shimizu H; Hashimoto T
Br J Dermatol; 1996 Feb; 134(2):340-6. PubMed ID: 8746353
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of blister induction by autoantibodies.
Sitaru C; Zillikens D
Exp Dermatol; 2005 Dec; 14(12):861-75. PubMed ID: 16274453
[TBL] [Abstract][Full Text] [Related]
33. Bullous autoimmune estrogen dermatitis.
Mutasim DF; Baumbach JL
J Am Acad Dermatol; 2003 Jul; 49(1):130-2. PubMed ID: 12833026
[TBL] [Abstract][Full Text] [Related]
34. [Bullous autoimmune dermatoses. 2: Pathogenesis].
Hertl M; Schuler G
Hautarzt; 2002 Apr; 53(4):277-85; quiz 285, 287. PubMed ID: 12053698
[No Abstract] [Full Text] [Related]
35. [Diagnostic use of autoantibodies].
Günther C; Hertl M; Meurer M
Hautarzt; 2007 Dec; 58(12):1063-74; quiz 1075. PubMed ID: 18030435
[TBL] [Abstract][Full Text] [Related]
36. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
Chan LS; Cooper KD
Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
[TBL] [Abstract][Full Text] [Related]
37. [Wounds in autoimmune bullous dermatoses and systemic connective tissue diseases].
Marinović B; Jukić IL; Lipozencić J
Acta Med Croatica; 2012 Oct; 66 Suppl 1():13-7. PubMed ID: 23193815
[TBL] [Abstract][Full Text] [Related]
38. [Updates in autoimmune bullous skin diseases].
Amagai M
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Feb; 25(1):28-31. PubMed ID: 11963177
[No Abstract] [Full Text] [Related]
39. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
40. [Bullous autoimmune dermatoses (I): Pathogenesis and diagnosis].
Sitaru C; Goebeler M; Zillikens D
J Dtsch Dermatol Ges; 2004 Feb; 2(2):123-8; quiz 139-40. PubMed ID: 16279248
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
